Sorbent Therapeutics Obtains $36,000,000 Series B Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bc10be59-c9a6-4efa-8c78-6195950fedee&Preview=1
Date 6/30/2011
Company Name Sorbent Therapeutics
Mailing Address 710 Lakeway Drive Sunnyvale, CA 94085
Company Description Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.